XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities      
Net loss   $ (73,464) $ (10,589)
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation expense   2,657 382
Depreciation and amortization   503 272
Accretion and amortization of investments, net   116  
Non-cash lease expense   220 124
Change in fair value of preferred stock purchase right liability $ (3,383) 40,163 (3,383)
Change in fair value of derivative liability     (858)
Non-cash loss from extinguishment of debt 752   752
Non-cash interest expense on convertible notes 283   472
Others   (15)  
Changes in operating assets and liabilities:      
Prepaid expenses and other assets   (3,355) 28
Accounts payable and accrued and other liabilities   2,523 1,069
Net cash used in operating activities   (30,652) (11,731)
Cash flows from investing activities      
Purchases of property and equipment   (6,442) (1,306)
Purchases of short-term investments   (144,916)  
Maturities of short-term investments   20,000  
Net cash used in investing activities   (131,358) (1,306)
Cash flows from financing activities      
Proceeds from issuance of convertible preferred stock, net of issuance costs   64,321 38,417
Proceeds from initial public offering, net of issuance costs   265,461  
Proceeds from stock option exercises   322  
Proceeds from early exercise of stock options   12 42
Proceeds from issuance of convertible notes, net of issuance costs     5,986
Net cash provided by financing activities   330,116 44,445
Net increase in cash and cash equivalents   168,106 31,408
Cash, cash equivalents, and restricted cash beginning of period   20,875 7,956
Cash, cash equivalents, and restricted cash end of period 39,364 188,981 39,364
Reconciliation of cash, cash equivalents and restricted cash to the balance sheet:      
Cash and cash equivalents 39,095 188,568 39,095
Restricted cash 269 413 269
Total cash, cash equivalents and restricted cash $ 39,364 188,981 39,364
Non-cash investing activities:      
Property and equipment included in accounts payable and accrued liabilities   825 $ 329
Non-cash financing activities:      
Deferred offering costs included in accounts payable and accrued liabilities   $ 331